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Abstract 
Osteogenesis imperfecta (OI) is a genetic disorder characterised by low bone mineral density 
resulting in fractures. 85-90% of patients with OI carry a variant in the type 1 collagen genes, 
COL1A1 and COL1A2, which follows an autosomal dominant pattern of inheritance. 
However, within the last two decades, there have been growing number of variants identified 
in genes that follow an autosomal recessive pattern of inheritance.  
Our proband is a child born in Mexico with multiple fractures of ribs, minimal calvarial 
mineralisation, platyspondyly, marked compression and deformed long bones. He also 
presented with significant hydranencephaly, requiring ventilatory support from birth, and 
died at 8 days of age. A homozygous c.338_357delins22 variant in exon 2 of SERPINH1 was 
identified. This gene encodes heat shock protein 47, a collagen-specific chaperone which 
binds to the procollagen triple helix and is responsible for collagen stabilisation in the 
endoplasmic reticulum.  
There is minimal literature on the mechanism of action for variants in SERPINH1 resulting in 
osteogenesis imperfecta. Here we discuss this rare, previously unreported variant, and expand 
on the phenotypic presentation of this novel variant resulting in a severe, lethal phenotype of 
OI in association with hydranencephaly. 
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Introduction 
Osteogenesis imperfecta (OI) is a heritable condition characterised by fragile bones of 
varying severity (Bishop et al., 2010). Extra-skeletal features are often present, such as blue 
sclerae, skin hyperextensibility, dentinogenesis imperfecta and hearing loss (Forlino & 
Marini 2016; Marini et al., 2013). 
85- 90% of OI cases are due to an autosomal dominant variant in the genes encoding type I 
collagen, COL1A1 and COL1A2 (Forlino & Marini 2016). There are several hundred 
recorded variants in these genes, the most common being a glycine substitution in the 
collagen triple helix (Lindahl et al., 2015). 
More recently, variants in other genes have been identified as causing autosomal recessive 
forms of OI. Most of these genes are involved in post-translational modification of type I 
collagen in the endoplasmic reticulum (ER). CRTAP (OMIM *605497), LEPRE1 (OMIM 
*610339) and PPIB (*OMIM 123841) are genes encoding components of the prolyl-3 
hydroxylation complex which undertakes post-translational alterations of the procollagen 
molecule. The modifications are necessary for folding, secretion and extracellular matrix 
assembly; pathogenic variants in any of the three genes cause posttranslational over-
modification resulting in bone fragility (Barbirato et al., 2015; Duran et al., 2015). Heat 
shock protein 47 (HSP47) encoded for by SERPINH1 (OMIM *600943), is a collagen-
specific chaperone expressed in all collagen-secreting cells. It binds to the procollagen triple 
helix and is required for the proper assembly of the triple helical procollagen molecules after 
the modification by the prolyl-3 hydroxylation complex (Ishida et al., 2006; Widmer et al., 
2012; Duran et al., 2015). FKBP10 (OMIM 607063) encodes for FKBP65, a type I collagen 
chaperone present in the ER along with HSP47. Variants in this gene results in two distinct 
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phenotypes: moderately severe OI and Bruck Syndrome (OI with contractures) (Duran et al., 
2015). 
Here we present a male patient diagnosed with severe bone fragility and hydranencephaly 
who did not survive past the neonatal period. This was caused by a novel homozygous variant 
in SERPINH1.  
Clinical Summary 
The patient was a male, born in Mexico to healthy, non-consanguineous parents. The parents 
were young at the time of birth: the mother was 15 years of age and the father was 17 years of 
age. In the second trimester, the pregnancy was complicated by ultrasound findings in the 
fetus of ascites, pleural effusion, short long bones and cerebral ventriculomegaly, 
amniocentesis revealed a 46,XY[30] karyotype. The ascites and pleural effusion 
spontaneously resolved in the third trimester. He was delivered by caesarean section at 36 
weeks gestation with a birth weight of 1600 grams (<3 percentile), length of 35 cm (<3 
percentile) and head circumference of 32 cm (50 percentile). Apgar scores were 5 at 1 minute 
and 7 at 5 minutes of age. Continuous assisted ventilation support was required from birth. 
Physical examination revealed generalised hypotonia, relative macrocephaly, soft skull with 
enlarged and bulging anterior and posterior fontanelle, short neck, narrow and bell-shaped 
chest, right undescended testis, flexed and abducted right hip with asymmetrical, short and 
bowed limbs. Facial dysmorphism included high and prominent forehead, mid-face 
hypoplasia, deep-set eyes with down-slanting palpebral fissures, blue sclerae, short nose, 
anteverted nares, retrognathia and bilateral low-set ears. The infant passed away at eight days 
of age following a prolonged stay in neonatal intensive care with hemodynamic instability 
and pulmonary haemorrhage.  
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Radiographs showed narrow chest, multiple fractures of ribs, minimal calvarial 
mineralisation, platyspondyly, marked compression, osteopenia and deformed long bones, 
consistent radiologically with type II osteogenesis imperfecta. Cerebral ultrasound reported 
hydranencephaly, but magnetic resonance study was not undertaken. 
Materials and Methods 
Genomic DNA was extracted using standard protocols. Clonal sequencing using SureSelect 
target enrichment (Agilent Technologies) and the Illumina MiSeq platform was performed 
using a custom designed gene panel: COL1A1; COL1A2; IFITM5; CRTAP; LEPRE1; PPIB; 
FKBP10; SP7; SERPINF1; SERPINH1; PLOD2; BMP1; TMEM38B; WNT1. Analysis of 
sequence data using a custom designed bioinformatics pipeline based on the open source 
workflow by the Broad Institute (http://www.broadinstitute.org/gatk/guide/best-practices) 
was undertaken using a minimum threshold of 30-fold read depth for exonic sequence and 
intron/exon boundary. Variants identified were filtered against polymorphism lists and 
assessed using the Association for Clinical Genetic Science Best Practice Guidelines for the 
evaluation of pathogenicity and the reporting of sequence variants in clinical molecular 
genetics (http://www.acgs.uk.com); no other pathogenic variants were identified in other 
genes in the panel.  Parental testing was performed through targeted analysis by Sanger 
sequencing. 
Results 
Genetic analysis was undertaken with informed consent which revealed a homozygous 
c.338_357delins22 variant in exon 2 of the SERPINH1 (NM_001235.3). This is predicted to 
result in a frameshift and lead to a premature termination codon 7 amino acids downstream. 
This change has not been reported previously in SERPINH1. However, similar frameshift 
variants have been reported in other autosomal recessive genes in OI. 
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(http://www.le.ac.uk/ge/collagen/). The parents were confirmed to be heterozygous carriers 
of this variant. 
Discussion 
This case report adds to the minimal published literature on OI associated with SERPINH1 
variants. Here we report a child with OI caused by a homozygous c.338_357delins22 variant 
in exon 2 in SERPINH1, which is novel in that it results in a premature termination codon. A 
potential mechanism of action for this variant and how it causes a lethal phenotype is 
suggested below. 
The first identified cases of OI caused by a variant in SERPINH1 were in pedigree 
Dachshunds (Drogemuller et al., 2009). However, the gene had previously been known in 
obstetrics, as variants in the promoter region increase the risk of preterm premature rupture of 
membranes in African-American women (Wang et al., 2006). 
It is known that mutant mice deficient in SERPINH1 suffer from defective collagen synthesis 
and die at around Day-11 of development with abnormal epithelial tissues and ruptured blood 
vessels (Nagai et al., 2000; Drogemuller et al., 2009). In humans, fibroblasts without HSP47 
produce collagen fibrils that are abnormally long and thin (Ishida et al., 2006). The collagen 
chaperone appears to have several roles in the precise manufacture of the collagen molecule. 
HSP47 is a collagen-specific chaperone found in ER and encoded by SERPINH1. The main 
function of HSP47 is to stabilise folded collagen and Serpinh1 KO mice are embryonic lethal. 
HSP47 binds directly onto the triple helix region of procollagen molecules after they have 
undergone the first modification in the ER by the prolyl-3 hydroxylation complex. There it 
functions as a stabilisation mechanism for the molecule and marks the folded collagen for 
transportation to the Golgi (Forlino and Marini, 2015). HSP47 also aids quality control, as 
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imperfect collagen molecules are not marked for movement out of the ER (Nagai et al., 
2000). It then dissociates from the triple helix either in the cis-Golgi or the ER-Golgi 
LQWHUPHGLDWHFRPSDUWPHQWSHUKDSVPHGLDWHGE\WKH*ROJL¶VORZHUS++SP47 is transported 
back to the ER to repeat the process (Widmer et al., 2012). 
At body temperature, mature collagen is thermally unstable: the procollagen triple helix 
spontaneously forms its native conformation at temperatures several degrees below body 
temperature, but not at 37oc. To do this, it requires the attachment of HSP47 to stabilise the 
molecule (Makareeva and Leikin, 2007). If insufficient HSP47 is present within the cell, the 
secreted type I collagen denatures quickly at body temperature when exposed to proteases 
(Christiansen et al., 2010; Widmer et al., 2012). It is thought that the binding of HSP47 
prevents local unfolding of the triple helical regions at body temperature: this does not occur 
in OI, as there are reduced levels of the chaperone (Widmer et al., 2012). 
In cells without HSP47, the secretion of type I collagen to the Golgi is delayed, resulting in 
an accumulation of insoluble procollagen aggregates within the endoplasmic reticulum. This 
delayed secretion may be due to the abnormal structure of the collagen produced (Ishida et 
al., 2006). Alternatively, it may be caused by a lack of HSP47 on the binding sites of the 
triple helix: procollagen has a tendency to form lateral aggregates and the chaperones may 
inhibit this (Widmer et al., 2012). 
When there is deficient or no HSP47, the collagen produced by the fibroblasts is inadequate 
(Ishida et al., 2006) and causes bone to be inefficiently mineralised. Hence, a bone fragility 
phenotype arises and bone fragility results. Given the truncating variant in our patient 
reported here, it is likely that there is a quantitative defect in Heat shock protein 47 (HSP47) 
encoded for by SERPINH1 resulting in defective collagen contributing to severe bone 
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Other cases where variants in SERPINH1 have resulted in an OI phenotype include three 
patients with missense pathogenic variants in the gene: 2 siblings were diagnosed with 
moderately severe OI (c.710T>C) after infancy (Duran et al., 2015) and one other patient 
suffered from severe OI before passing away from respiratory distress (c.233T>C) 
(Christiansen et al., 2010). Both variants resulted in an amino acid substitution within the 
gene, which impaired its function. Additionally of note, consanguinity was present in both the 
families.  
However, our proband had a truncating variant in the SERPINH1 gene resulting in a lethal OI 
phenotype. It seems likely that because the outcome of the variant is a premature termination 
codon, there would be resulting nonsense mediated decay of the abnormal mRNA. This 
would suggest that there may be less HSP47 within the ER with resultant loss of function 
causing a more severe phenotype: as with less HSP47, the collagen molecules would be more 
irregularly structured and unstable. 
Conclusions and Summary 
The multiple roles of HSP47 within the ER, and the phenotype that is a consequence of its 
deficiency, show that the chaperone is vital for the proper production of collagen. This report 
adds to the minimal published literature on the severe, lethal OI phenotype associated with 
SERPINH1 variants. This is the first report of a truncating variant in SERPINH1 and adds to 
the growing number of OI presentations caused by recessive gene variants. 
Figure Legends: 
Figure 1a demonstrating relative macrocephaly, high and prominent forehead, mid-face 
hypoplasia, deep-set eyes with down-slanting palpebral fissures, short nose, anteverted nares, 
retrognathia and bilateral low-set ears. There was also evidence of short neck, narrow and 
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bell-shaped chest, flexed and abducted right hip with asymmetrical, short and bowed limbs 
and need for ventilatory support soon after birth 
Figure 1b radiograph demonstrating multiple fractures of ribs, minimal calvarial 
mineralisation, platyspondyly, marked compression, osteopenia and deformed long bones, 
consistent radiologically with type II Osteogenesis Imperfecta. Figure 1c Cerebral ultrasound 
demonstrating severe ventriculomegaly and remnants of brain tissue. 
Figure 2a-b radiograph demonstrating bowed limbs, multiple fractures and severe osteopenia 
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